ArticleBiomedicines2024

Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy.

Jan Nicolai Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.